Latest Regulatory News

Following its December 2025 ASX debut and a successful IPO, Saluda Medical reports robust global revenue growth and expands its US sales force, prompting an upward revision of its FY26 revenue guidance.

Clever Culture Systems has expanded its APAS Independence installed base to 27 instruments globally and surpassed $1 million in annual recurring revenue, underpinned by strong sales momentum and customer validation.

Finder Energy Holdings has completed the acquisition of the Petrojarl I FPSO, a critical step that de-risks the KTJ Project and accelerates its path to a Final Investment Decision expected by mid-2026. The company also secured A$25 million in funding and achieved a significant resource upgrade.

Firebrick Pharma has commenced commercial manufacturing and export of its new Nasodine Throat Spray, marking a significant step in its international expansion. The company also reported a 15% increase in cash sales and reduced operating costs, signalling improving financial health.

Mitchell Services Limited has reported a remarkable first half of FY26, posting a 71% increase in quarterly EBITDA and achieving a net cash position of $7.2 million. The company’s strong operating cashflows and improved market conditions underpin its optimistic outlook.

Grand Gulf Energy has progressed its Petroleum Exploration Licence application offshore Namibia and continued development discussions for its Red Helium Project, maintaining a disciplined capital approach during the December 2025 quarter.

Metals Australia Ltd is progressing pre-feasibility studies for its Lac Carheil Graphite Project in Quebec, aligning with the province’s new strategy to accelerate critical minerals development. The project’s expanded resource and downstream battery material plans position it well for North American markets.

EMVision Medical Devices reports strong clinical trial progress for its portable brain scanners, backed by solid cash reserves and milestone grant funding.

Argenica Therapeutics has unveiled compelling AI-driven results confirming ARG-007’s significant benefits in severe acute ischemic stroke patients, setting the stage for a precision-focused Phase 2b trial.

WA1 Resources reports exceptional assay results from the Luni Niobium Project alongside significant pre-development progress and government recognition as a Major Project.

Aurora Energy Metals has taken significant strides in its uranium exploration strategy, progressing Eagle Energy Metals’ planned Nasdaq listing and securing new Western Australian exploration assets. These developments position the company for growth amid evolving market dynamics.

Antipa Minerals has reported a significant resource upgrade and strong drilling results at its Minyari Dome project, advancing its pre-feasibility study towards a mid-2028 investment decision.